Arbro Formulations Private Limited
About Arbro Formulations Private Limited
Data last updated:
Arbro Formulations Private Limited is a private limited company based in Delhi, India, a subsidiary of Arbro Pharmaceuticals Private Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 March 2022.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24230DL2022PTC395692. Its GSTIN is 07AAWCA7328Q1ZO (Delhi). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Saurabh Arora and Vijay Kumar Arora.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 6/14 Kirti Nagar Industrial Area, Delhi, India – 110015.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.62 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹55.7 Lakh (net margin -15.4%) and EBITDA of ₹74.41 Lakh (EBITDA margin 20.5%).
As per MCA filings, the company has open charges of ₹20.44 Cr on record.
Company details
Contact details
Arbro Formulations Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address6/14 Kirti Nagar Industrial Area, Delhi, India – 110015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Arbro Formulations Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Arbro Formulations is manufacturing. In detail, this covers manufacture of chemicals and chemical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 20 | Manufacture of chemicals and chemical products |
To see the full business activity and turnover split of Arbro Formulations Private Limited, buy the company report.
Financials of Arbro Formulations Private Limited
FY 2025 filings availableArbro Formulations Private Limited reported revenue of ₹3.62 Cr (up 67733% YoY) for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹74.41 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹55.7 Lakh | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 20.5% | |||
| Net Profit Margin | -15.4% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Arbro Formulations Private Limited, buy the company report.
Board of directors of Arbro Formulations Private Limited
Arbro Formulations has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Saurabh Arora | Director | 29 Mar 2022 | 4 Years 7 Months | Current |
| Vijay Kumar Arora | Director | 29 Mar 2022 | 4 Years 7 Months | Current |
Auditor
Arbro Formulations Private Limited is audited by SATINDER SAINI & COMPANY for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SATINDER SAINI & COMPANY | FY 2024 | 008834N |
Shareholding
The shareholding of Arbro Formulations Private Limited is on record for 2 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Arbro Formulations Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 17 Jan 2025 | 101052694 | Others | ₹4 Cr | Open | |
| 17 Jan 2025 | 101052704 | Others | ₹4 Cr | Open | |
| 29 Aug 2024 | 100969735 | Others | ₹3 Cr | Open | |
| 04 Jul 2024 | 100948696 | Others | ₹2 Cr | Open | |
| 06 Jul 2023 | 100769395 | Tata Capital Financial Services Limited | ₹4.88 Cr | Open |
Total charge records: 6 View all charges
Legal cases
No court or tribunal cases involving Arbro Formulations Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Arbro Formulations Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Arbro Formulations Private Limited has 1 active EPFO establishment as of Feb 27, 2025.
GST
Arbro Formulations has 2 GST registrations: 2 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAWCA7328Q1ZO | Delhi | Active | 03 May 2023 |
| 02AAWCA7328Q1ZY | Himachal Pradesh | Active | 14 Jul 2023 |
To see the full GST registrations and return filing status of Arbro Formulations Private Limited, buy the company report.
Recent activity
Arbro Formulations Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Saurabh Arora was appointed as Director on 29 Mar 2022.
Frequently asked questions
Arbro Formulations is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 March 2022 (4+ years old) and is registered under CIN U24230DL2022PTC395692.
Arbro Formulations has 2 current directors:
- Saurabh Arora - Director
- Vijay Kumar Arora - Director
The latest financial statements of Arbro Formulations on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Arbro Formulations is 07AAWCA7328Q1ZO, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 02AAWCA7328Q1ZY (Himachal Pradesh).
The CIN (Corporate Identification Number) of Arbro Formulations is U24230DL2022PTC395692. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Arbro Formulations was incorporated on 29 March 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.
Saurabh Arora was appointed as Director on 29 Mar 2022. Vijay Kumar Arora was appointed as Director on 29 Mar 2022.
The registered office of Arbro Formulations is at 614 Kirti Nagar Industrial Area, Delhi, India – 110015.
Arbro Formulations operates in the pharma industry, in the drug formulation and development segment.
Arbro Formulations has open charges of ₹20.44 Cr and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
